Latur Super Speciality Hospital Pvt Ltd

Nanded Road , Garud Chowk Latur 413512

PI: Dr Ajay Punpale ( Surgical Oncologist )

Below Mentioned Study Ongoing .

1. A multi-center, open-label, balanced, randomized, two-treatment, two-period, twosequence,two-way crossover, multiple-dose, steady-state bioequivalence study of Pazopanib HCl Tablets 200mg (4 Tablets X 200 mg) of MSN Laboratories Private Limited, India compared with Votrient® Tablet200mg (4 Tablets X 200 mg) of Novartis Pharmaceuticals Corporation, USA in Advanced renal cellcarcinoma patients who are already receiving Pazopanib HCl tablets in standard therapy, and who are tolerating a stable dosing regimen of 800 mg/day under fasting conditions.